January 18, 2019 / 11:59 AM / 4 months ago

India's Sun Pharma asks regulator to examine media report

FILE PHOTO: A bird flies past the logo of Sun Pharmaceutical Industries Ltd. installed on the facade of its corporate office in Mumbai, India, May 25, 2018. REUTERS/Francis Mascarenhas

(Reuters) - Sun Pharmaceutical Industries Ltd (SUN.NS) on Friday asked India’s capital markets regulator to look into a media report about an alleged complaint by a whistleblower that led to a sell-off in the company’s shares.

In a letter to the Securities and Exchange Board of India (SEBI), Sun Pharma said there was “great asymmetry in the information circulating between analysts, investors and media leading to intense speculation.”

Reporting by Tanvi Mehta in Bengaluru; Editing by Mark Potter

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below